| Document |
Document Title |
|
WO/1999/058509A1 |
The invention relates to a method for producing isoxazolene of the formula (I), where the substituents have the following meanings: R?1¿ is hydrogen, C¿1?-C¿6? alkyl, R?2¿ is C¿1?-C¿6? alkyl, R?3¿, R?4¿, R?5¿ are hydrogen, C¿1?...
|
|
WO/1999/057095A2 |
The invention relates to a process for the preparation of (±)-4-(S,R)- [(3,4-dichlorophenyl) -3,4-dihydro-1(2H) -naphthalene-1-ylidene] -methylamine of Formula (I) by reacting 4-(3,4-dichlorophenyl) -3,4-dihydro-1(2H) -naphthalene-1-one...
|
|
WO/1999/056699A2 |
The present invention relates to a method and catalysts for the stereoselective addition of a nucleophile to a reactive $g(p)-bond of a substrate. The chiral, non-racemic catalysts of the present invention constitute the first examples o...
|
|
WO1999036395A9 |
A hydroxydiphenylamine compound can be converted to an N-phenylquinoneimine by reacting the hydroxydiphenylamine with oxygen or an oxygen containing gas in the presence of a modified activated carbon catalyst, the catalyst having had sur...
|
|
WO/1999/055686A2 |
4-(3,4-Dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-ylidene-m
ethylamine and related analogs are prepared form $g(a)-tetralone by a facile three-step process. This compound is the required intermediate to prepare sertraline, (1S-cis)-4-(3...
|
|
WO/1999/055665A1 |
The invention relates to novel azines, to a method for producing said azines and to their use as fungicides.
|
|
WO/1999/055830A2 |
The invention encompasses a process for making compounds of Formula (I) useful in the treatment of cyclooxygenase-2 mediated diseases.
|
|
WO/1999/054516A1 |
Alternative equilibrium modifiers for use with aldoxime extractants, such as hydroxyl aryl aldoxime extractants, employed in the process for extraction of metal values, particularly copper values, in the extraction from aqueous solutions...
|
|
WO/1999/052848A1 |
This invention relates to ketones, alcohols and amines and acids represented by the likes of 3-(3-cyclopentyloxy-4-methoxyphenyl)-3-phenylcyanoclobutan-1
-one. They are useful as PDE 4 antagonists.
|
|
WO/1999/052860A1 |
A hydroxyphenylamine compound can be converted, with high yield and high selectivity, into its corresponding quinoneimine by reacting the hydroxyphenylamine with a hypochlorite oxidation reactant.
|
|
WO/1999/052859A1 |
A hydroxyphenylamine compound can be converted, with high selectivity, into its corresponding quinoneimine by reacting the hydroxyphenylamine with hydrogen peroxide in the presence of a catalyst.
|
|
WO/1999/052878A1 |
The invention relates to novel substituted phenyl pyridazinones of formula (I), wherein R?1¿, R?2¿, R?3¿, R?4¿, R?5¿ and R?6¿ have the meanings cited in the description. The invention also relates to the production and use thereof ...
|
|
WO/1999/051579A1 |
The invention concerns fungicide compounds of general formula (I) and compositions containing them, wherein G is selected among the groups (G1) to (G9), the other substituents being such as defined in the description. The invention also ...
|
|
WO/1999/051567A1 |
A process for producing an (E)-hydroxyiminoacetamide derivative (II) represented by general formula (II), which is an important intermediate for an agricultural bactericide, characterized by using hydroxylamine sulfate as a reagent for c...
|
|
WO/1999/050231A1 |
A process for efficiently producing an (E)-oxime compound from a dialkyl oxalate and an organomagnesium halide without the need of a complicated separation operation, characterized by: (a) reacting an organomagnesium halide represented b...
|
|
WO/1999/050232A1 |
Compounds of formula (I), wherein: A is a group OCHR¿4? or N=CR¿4?; Y is O or NH; R¿1? is C¿1?-C¿6?-alkyl; R¿2? is C¿1?-C¿6?-alkyl or C¿1?-C¿6?-alkyl substituted by 1 to 5 fluorine atoms; R¿3? is C¿1?-C¿6?-alkyl, C¿1?-C¿6?...
|
|
WO/1999/050273A1 |
Transition metal imine complexes can be prepared by reacting the imine precursors, a carbonyl compound and a primary amine, in the presence of a selected transition metal compound. The complexes may be used as catalysts for olefin polyme...
|
|
WO/1999/048861A1 |
The invention concerns: a) methyl-phenyl derivatives of general formula (I) wherein R¿1? represents OH, C¿3?-C¿7? alkyl, or C¿3?-C¿7? cycloalkyl, said compounds being in the form of individual isomers or mixtures thereof; b) the met...
|
|
WO/1999/046233A1 |
Benzyl alcohol derivatives represented by general formula (I) and a process for producing the same; wherein R?1¿ represents cyano or -COOR?2¿ (wherein R?2¿ represents linear C¿1-5? alkyl); and a process for producing from the above b...
|
|
WO/1999/046238A1 |
A hydrazide fixed to a resin represented by formula (1): P-Q-CO-NH-NH¿2? wherein P represents a main chain of a polymer constituting the resin and Q represents a hydrocarbon side chain optionally substituted with a substituent which may...
|
|
WO/1999/046239A1 |
An imine fixed to a resin characterized in that it is represented by the following formula: P-Q-N=CH-R wherein P represents a main chain of a polymer constituting the resin, Q represents a hydrocarbon side chain optionally substituted wi...
|
|
WO/1999/043634A2 |
Preparation of oximes starting from cardanol, constituent of cashew nut shell liquid (CNSL); the products resulting from chemical reactions, are applied in solvent extraction process, for the recovery of gallium, rare earths and other me...
|
|
WO/1999/043643A2 |
A method is provided for the transition metal-catalyzed arylation, or vinylation, of hydrazines, hydrazones, and the like. Additionally, the invention provides a conceptually novel strategy, the cornerstone of which is the transition met...
|
|
WO/1999/040062A1 |
Hydrazone-derivatives of formula (I) or (II), their salts, hydrates and optical isomers. Compositions comprising the compounds, the use of these compounds as medicaments and their use in therapy especially in the treatment of diseases re...
|
|
WO/1999/037610A1 |
Novel trifluoromethylated intermediates are provided which are useful in synthesizing trifluoromethylated organic compounds. Specifically, compounds of the formula CF¿3?CR are provided, wherein R is (C1)=CHCH¿2?SO¿2?Ph, (C1)=CHCH¿2?C...
|
|
WO/1999/037600A1 |
The present invention relates to diterpene derivatives prepared from the components which are extracted from Acanthopanax Koreanum and represented by Chemical Formula (1).
|
|
WO/1999/036393A1 |
The present invention relates to a pharmaceutical composition comprising as an active ingredient a compound of formula (I), wherein Ring A is an aromatic or a heterocyclic ring; Q is a bond, carbonyl, lower alkylene, lower alkenylene, -O...
|
|
WO/1999/036394A1 |
This invention relates to a novel improved process for preparation of N-[4-(3,4- dichlorophenyl) -3,4-dihydro-1(2H)- naphthalenylidene]methanamine from 4-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone and monomethylamine.
|
|
WO/1999/029700A2 |
Compounds of formula (I) exhibiting pesticidal activity in which X is CH or N; Y is O; S, S=O or NR¿5?; Z is OR¿2?, SR¿2?, N(R¿3?)R¿4?; or Y and Z together form a 5- to 7-membered ring which contains 2 or 3 hetero atoms O and/or N a...
|
|
WO/1999/027783A1 |
Fungicidal compositions and methods comprising acylated aminosalicylamides (AASA) described herein. Novel cyclic amines and 3-nitrosalicylamides, and their use as pesticides and in the preparation of the antifungal AASA compounds are als...
|
|
WO/1999/028984A1 |
The invention concerns novel electrode materials derived from polyquinoid ionic compounds and their uses such as in electrochemical generators. It concerns in particular compounds such as a rhodizonic acid salt; a rufigallic acid salt; a...
|
|
WO/1999/028305A1 |
Compounds of Formula (I), and their $i(N)-oxides and agriculturally suitable salts, are disclosed which are useful as fungicides and arthropodicides wherein T is (T?1¿), (T?2¿), (T?3¿), or (T?4¿); YZ is a group consisting of (a) 3 or...
|
|
WO/1999/026611A1 |
The present invention provides substituted 3,3-diphenyl indanone, indane and indole compounds, as well as analogues thereof, which are specific, potent and safe inhibitors of mammalian cell proliferation. The compounds can be used to inh...
|
|
WO/1999/026918A1 |
Biphenylamidine derivatives represented by general formula (1) or pharmaceutically acceptable salts thereof, both being novel compounds functioning as clinically applicable Fxa inhibitors.
|
|
WO/1999/025335A1 |
A new family of inadone and tetralone tubulin-binding compounds (TBs) is disclosed. Unlike classical TBs, which inhibit mitosis among affected dividing cells, the TBs of the invention possess two unique properties: (1) they induce apopto...
|
|
WO/1999/024393A1 |
The present invention includes a number of novel intermediates such as the (S)-secondary alcohol of formula (VIIIA) X¿2?-CH¿2?-C*H(OH)-CH¿2?-NH-CO-R¿N? and processes for production of pharmacologically useful oxazolidinones.
|
|
WO/1999/021823A1 |
Intermediates having formulas (A) and (B) wherein B?I¿ is -CH¿2?OH or -CH¿2?OR?P¿, and R?P¿ is an alcohol protecting group; a is 1, 2, or 3; T?I¿ is -OH or (C); Q?I¿ is phenyl, naphthyl or heteroaryl having 1-3 substituents; R?a¿...
|
|
WO/1999/021819A1 |
A phenylenediamine compound can be converted, with high selectivity, into its corresponding quinonediimine by reacting the phenylenediamine with hydrogen peroxide in the presence of a catalyst.
|
|
WO/1999/021826A1 |
A phenylenediamine compound can be converted, with high selectivity, into its corresponding quinonediimine by reacting the phenylenediamine with a hypochlorite oxidation reactant.
|
|
WO/1999/021827A1 |
A phenylenediamine compound can be converted, with high selectivity, into its corresponding quinonediimine by reacting the phenylenediamine with oxygen in the presence of a modified activated carbon catalyst in an aqueous system.
|
|
WO/1999/020630A1 |
A photochromic compound has the formula (I) wherein R?1¿ is selected from the group including substituted amino aryl moieties, substituted cyclic amino aryl moieties and substituted $i(N)-indolinoaryl or $i(N)-tetrahydroquinolino aryl g...
|
|
WO/1999/020667A1 |
A novel high-performance polymer which is usable as a polymeric coagulant in centrifugal drying, belt-press drying, or the like and can attain a satisfactory dewatering rate. The polymer is a water-soluble vinyl polymer (A) which contain...
|
|
WO/1999/019311A1 |
The invention relates to novel azines of formula (I), wherein G stands for a single bond or group (a) wherein R?1¿means respectively optionally substituted alkyl, alkenyl, alkinyl or cycloalkyl, R represents alkyl or optionally substitu...
|
|
WO/1999/016748A1 |
The invention relates to novel spirocyclic phenyl keto-enols of general formula (I) in which Het represents one of the groups (1), (2) or (3), Q represents (A); (B); (C); (D); (E) or (F), and X, Y, Z, m, n, R?6¿, R?9¿, R?10¿, R?11¿ h...
|
|
WO/1999/013920A2 |
The invention relates to a method for treating proliferative diseases by therapy, characterised in that an application catheter is first placed at the site of the lesion and a radioactive substance is applied locally. The catheter is the...
|
|
WO/1999/012877A1 |
The invention concerns a method for the enantioselective reduction of prochiral ketones into chiral alcohol's comprising the following steps: a) reacting a prochiral ketone with a silane agent, present in stoichimetric amount, in the pre...
|
|
WO/1999/012892A1 |
The invention relates to substituted alkenoic acids and their derivatives, said substituted alkenoic acids being of formula (I), wherein R?1¿ represents hydroxy, amino, alkoxy, alkylamino, dialkylamino, arylalkoxy or arylalkylamino, R?2...
|
|
WO/1999/012911A1 |
The invention relates to a method for producing N-acylated (hetero)aromatic hydroxylamine derivatives of formula (I), wherein the substituents, the ring atom and the index have the meanings given in the Description, by hydrogenating a (h...
|
|
WO/1999/012885A1 |
The invention relates to novel substituted alkenoic acids and their derivatives, to methods for producing them, and to their use as fungicides.
|
|
WO/1999/010546A1 |
A process for the solvent extraction of metals, particularly copper, from aqueous ammoniacal solutions is provided. The extractant is an orthohydroxyarylketoxime of Formula (1), wherein R?1¿ is a hydrocarbyl group, and R?2¿ is an ortho...
|
